CRYOPORT, INC. Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent
CRYOPORT, INC. (CYRX) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent of -$3.67 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-04.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent · last filed 2023-05-04
- CRYOPORT, INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2023-03-31 was -$3.67M, a 126.13% decline year-over-year.
- CRYOPORT, INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2022-12-31 was -$2.47M, a 202.44% decline year-over-year.
- CRYOPORT, INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2022-09-30 was $6.54M, a 1602.34% increase year-over-year.
- CRYOPORT, INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for the quarter ending 2022-06-30 was $5.31M, a 1129.17% increase year-over-year.
- CRYOPORT, INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2022 was $23.44M, a 492.19% increase from fiscal 2021.
- CRYOPORT, INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2021 was $3.96M.
- CRYOPORT, INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2020 was -$161.00K, a 675.00% decline from fiscal 2019.
- CRYOPORT, INC. other comprehensive (income) loss, defined benefit plan, after tax and reclassification adjustment, attributable to parent for fiscal 2019 was $28.00K.
| Period end | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 3 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 3 month as first filed | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 6 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 6 month as first filed | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 9 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 9 month as first filed | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 12 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | -$3.67M 10-Q · filed 2023-05-04 | -$6.15M derived: sum of 2 quarters · filed 2023-05-04 | $389.00K derived: sum of 3 quarters · filed 2023-05-04 | $5.70M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2022-12-31 | -$2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $4.06M derived: sum of 2 quarters · filed 2023-02-28 | $9.37M derived: sum of 3 quarters · filed 2023-02-28 | $23.44M 10-K · filed 2023-02-28 | ||||
| 2022-09-30 | $6.54M 10-Q · filed 2022-11-04 | $11.85M derived: sum of 2 quarters · filed 2022-11-04 | $25.91M 10-Q · filed 2022-11-04 | $28.33M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2022-06-30 | $5.31M 10-Q · filed 2022-08-04 | $19.37M 10-Q · filed 2022-08-04 | $21.79M derived: sum of 3 quarters · filed 2023-05-04 | $22.17M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2022-03-31 | $14.06M 10-Q · filed 2023-05-04 | $16.48M derived: sum of 2 quarters · filed 2023-05-04 | $16.86M derived: sum of 3 quarters · filed 2023-05-04 | $17.30M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $2.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.80M derived: sum of 2 quarters · filed 2023-02-28 | $3.23M derived: sum of 3 quarters · filed 2023-02-28 | $3.96M 10-K · filed 2023-02-28 | ||||
| 2021-09-30 | $384.00K 10-Q · filed 2022-11-04 | $816.00K derived: sum of 2 quarters · filed 2022-11-04 | $1.54M 10-Q · filed 2022-11-04 | $1.67M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $432.00K 10-Q · filed 2022-08-04 | $1.18M 10-Q · filed 2022-08-04 | $1.29M derived: sum of 3 quarters · filed 2023-02-28 | $1.40M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $768.00K 10-Q · filed 2022-05-05 | $858.00K derived: sum of 2 quarters · filed 2023-02-28 | $963.00K derived: sum of 3 quarters · filed 2023-02-28 | $1.11M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $195.00K derived: sum of 2 quarters · filed 2023-02-28 | $340.00K derived: sum of 3 quarters · filed 2023-02-28 | -$161.00K 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $105.00K 10-Q · filed 2021-11-04 | $105.02K 10-Q · filed 2020-11-06 | $250.00K derived: sum of 2 quarters · filed 2021-11-04 | -$251.00K 10-Q · filed 2021-11-04 | -$250.64K 10-Q · filed 2020-11-06 | -$209.38K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | $145.00K 10-Q · filed 2021-08-06 | $144.65K 10-Q · filed 2020-08-10 | -$336.00K 10-Q · filed 2021-08-06 | -$335.75K 10-Q · filed 2020-08-10 | -$314.38K derived: sum of 3 quarters · filed 2022-02-28 | -$258.49K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | -$471.00K 10-Q · filed 2021-05-06 | -$470.92K 10-Q · filed 2020-05-08 | -$459.38K derived: sum of 2 quarters · filed 2022-02-28 | -$403.49K derived: sum of 3 quarters · filed 2022-02-28 | -$441.40K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $11.62K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $67.51K derived: sum of 2 quarters · filed 2022-02-28 | $29.60K derived: sum of 3 quarters · filed 2022-02-28 | $28.00K 10-K · filed 2022-02-28 | $27.95K 10-K · filed 2020-03-10 | |||
| 2019-09-30 | $55.89K 10-Q · filed 2020-11-06 | $17.99K derived: sum of 2 quarters · filed 2020-11-06 | $16.38K 10-Q · filed 2020-11-06 | -$36.47K derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | -$37.91K 10-Q · filed 2020-08-10 | -$59.61K 10-Q · filed 2020-08-10 | -$92.36K derived: sum of 3 quarters · filed 2020-08-10 | -$92.36K derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | -$30.87K 10-Q · filed 2020-05-08 | -$54.45K derived: sum of 2 quarters · filed 2020-05-08 | -$54.45K derived: sum of 3 quarters · filed 2020-05-08 | -$54.45K derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | -$23.58K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$23.58K derived: sum of 2 quarters · filed 2020-03-10 | -$23.58K derived: sum of 3 quarters · filed 2020-03-10 | -$23.58K 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | $30.47K 10-Q · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | $30.47K 10-Q · filed 2018-11-08 | $0.00 derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | $0.00 derived: sum of 3 quarters · filed 2019-08-09 | $0.00 derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2019-05-09 | $0.00 derived: sum of 3 quarters · filed 2019-05-09 | |||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $0.00 derived: sum of 2 quarters · filed 2019-03-13 | $0.00 10-K · filed 2019-03-13 | |||||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |